In a context where global cooperation is needed perhaps more than ever before, how concerned should we be by efforts to “stockpile” potential treatments, and how can we encourage further cooperation? We look at the case of dexamethasone and remdesivir.
CGD Policy Blogs
The authors look at the feasibility of the drug dexamethasone in low-income countries.
As Nigeria begins to relax stay-at-home orders, Nigerian policymakers, with support from its development partners, should adjust restrictions in line with local circumstances and re-focus on the essential building blocks of health system strengthening.
Flatten the Curve without Flattening the Economy: How to Stop COVID-19 from Causing Another Catastrophe for Health in Low- and Middle-Income Countries
Dozens of low- and middle-countries (LMICs) have now implemented stringent policies to slow the spread of COVID-19 in communities, in an effort to flattern the curve. Yet flattening the curve comes at a cost–it also flattens the economy
Following wide criticism of the way the government had been formulating and communicating its COVID-19 response, particularly on its scientific rationale, the UK government has initiated daily public briefings on the evolving crisis. Below we run through the UK government’s communications so far, and outline recommendations for the government to improve its communication ever further, by revamping its whole evidence-informed decision-making approach.